Sowell Financial Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-30,167
| Closed | -$418K | – | 196 |
|
|
2021
Q4 | $418K | Buy |
30,167
+9
| +0% | +$125 | 0.02% | 454 |
|
|
2021
Q3 | $433K | Sell |
30,158
-2,227
| -7% | -$32K | 0.03% | 415 |
|
|
2021
Q2 | $512K | Buy |
32,385
+7,749
| +31% | +$123K | 0.03% | 414 |
|
|
2021
Q1 | $318K | Buy |
24,636
+12,941
| +111% | +$167K | 0.01% | 820 |
|
|
2020
Q4 | $87K | Buy |
11,695
+3,328
| +40% | +$24.8K | ﹤0.01% | 1205 |
|
|
2020
Q3 | $29K | Buy |
8,367
+7,183
| +607% | +$24.9K | ﹤0.01% | 1390 |
|
|
2020
Q2 | $6K | Buy |
+1,184
| New | +$6K | ﹤0.01% | 1831 |
|